This episode’s guest is Michael Levinsohn. Michael is a criminal and civil defense attorney with 20 years of experience representing people in all areas of the cannabis business. On the podcast, we discuss the legal aspects of practicing cannabis medicine, including: The need for more clinicians who are educated in cannabis medicine to help guide patients and defend them should …
Environmental Impacts of Cannabis Cultivation with Cindy Orser, PhD
On this episode, we talk with Cindy Orser, PhD, the Chief Scientific Officer at CLIP LABS. Dr. Orser has more than 25 years of experience innovating technologies related to cannabis, human diagnostics, and even detecting biothreat agents. We spent most of the conversation talking about the panel Cindy will moderate at CannMed 2021, titled “The Hidden Cost of Cannabis: Environmental …
Marker-Assisted Cannabis Breeding with Keith Allen, PhD
Keith Allen is the Director of Bioinformatics at Front Range Biosciences. Keith is tasked with exploring the cannabis genome to find genetic markers that can be selected in breeding projects. His current focus is on cannabinoid and terpene production, but as we discuss in our conversation, there are a number of different traits cannabis and hemp breeders will want to …
Cannabis Medicine for Geriatrics with Eloise Theisen, RN, AGPCNP-BC
On this episode, we talk with CannMed 2020 presenter Eloise Theisen of Radicle Health. Eloise is a board-certified Adult Geriatric Nurse Practitioner with over 20 years experience in nursing. She started her own cannabis practice about 6 years ago and she has treated over 6000 patients using cannabis. There are very few healthcare providers nationally with the same level of …
Evaluating Cannabis Testing Methods with Brianna Cassidy, PhD
On the latest episode of CannMed Coffee Talk, we welcome Brianna Cassidy, Chief Science Officer of CDX Analytics. Brianna and the team at CDX perform safety testing on all types of cannabis samples, including potency, pesticides, heavy metals, residual solvents, and microbial contamination. As you will hear in the podcast, Brianna takes a creative and analytical approach to solving problems …
Breeding Better Hemp Plants with Seth Crawford, PhD
We are excited to announce CannMed 2020’s Keynote Presenter in the Cultivation Focus Area, and our guest on the latest Coffee Talk Podcast, is Seth Crawford, PhD. Dr. Crawford is the owner and co-founder of Oregon CBD, along with his brother, Eric. Together (and with the help of some 41 scientists, geneticists and breeders) they specialize in turning out new, …
Testing Cannabis Products with Ini Afia
In this episode we get the chance to talk with our first representative from the Safety Focus Area. Ini Afia is the Scientific Director at CannaSafe Labs, one of the largest cannabis testing labs in California. If you aren’t familiar with what exactly goes on at a cannabis testing lab, you are likely in the majority. The cannabis testing labs …
Cannabis Medicine for Children with Bonni Goldstein, MD
We are excited to announce Bonni S. Goldstein, MD as the CannMed 2020’s Keynote Presenter in the Medicine Focus Area. The title of Dr. Goldstein’s presentation is “Cannabis Medicine for Children.” She will be sharing her latest clinical findings, including promising results from her clinical practice focusing on the use of phytocannabinoid medicines to treat serious pediatric medical condition, including …
Cannabis and COVID-19 with Martin A. Lee
In this episode of CannMed Coffee Talk we talk with Martin A. Lee, the co-founder and director of Project CBD. In addition to creating content for the Project CBD website and speaking at conferences around the globe, Martin has authored several books, including Smoke Signals: A Social History of Marijuana–Medical, Recreational and Scientific. In fact, we have a copy in our Medicinal …
The Endocannabinoid System 101 with Ethan Russo, MD
We are excited to announce CannMed 2020’s Keynote Presenter in the Science Focus Area is Dr. Ethan Russo. The title of Dr. Russo’s presentation is “Cannabis and Psychiatry: The Final Frontier”, and it will explore basic science and clinical trial data to assess the role of cannabis psychopharmacology with respect to issues of impairment, depression, insomnia, PTSD, schizophrenia, anxiety and …